Skip to content

EEG-Based Decision-Support Algorithm for Hypoxic-Ischemic Encephalopathy in Term Newborns

Retrospective Multicenter Validation of a Conventional EEG-Based Decision-Support Algorithm to Discriminate Mild Versus Moderate/Severe Hypoxic-Ischemic Encephalopathy in Term Newborns (Newborn Neuro Digital Project)

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07764315
Acronym
COOLDECIDE
Enrollment
310
Registered
2026-08-13
Start date
2026-09-16
Completion date
2027-02-16
Last updated
2026-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoxic-Ischemic Encephalopathy, Neonatal Brain Injury, Perinatal Asphyxia

Keywords

conventional EEG, therapeutic hypothermia, decision-support software, term newborn, diagnostic accuracy, medical device software

Brief summary

This retrospective, multicenter, observational study evaluates how well a decision-support algorithm can tell apart mild forms of hypoxic-ischemic encephalopathy (HIE) from moderate or severe forms in full-term newborns born after a lack of oxygen around birth (perinatal asphyxia). The algorithm reads the raw (non-compressed) EEG signal. Its output is compared with the reference reading of the full conventional EEG made by a panel of pediatric neurophysiologists together with the baby's clinical information. The study uses only medical data that already exists and asks nothing of the babies or their families.

Detailed description

The algorithm under investigation was developed in a previous retrospective clinical study (registered as NCT05114070; French CNIL/ethics ref CER-2021-023; approved by the Sorbonne University ethics committee) and is based on background-rhythm analysis of EEG. Newborns are analyzed in two subgroups: those who received a treatment liable to modify the EEG tracing, and those who did not. Conventional EEG recordings are collected from the neurophysiology departments of participating level-3 maternity hospitals over the period 01 January 2016 to 30 April 2026. No follow-up or sampling is performed.

Interventions

None listed

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER
BPI
CollaboratorUNKNOWN

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
0 Days to 1 Days
Healthy volunteers
No

Inclusion criteria

* No parental opposition to the use of the child's medical data within 1 month of the mailed information notice * Gestational age ≥ 36 weeks of amenorrhea * Birth weight ≥ 1800 g * Born in a context of perinatal asphyxia (any cause) leading to suspected HIE, with EITHER biological signs of metabolic acidosis (pH ≤ 7 or base deficit ≥ 16 mmol/L or lactate ≥ 11 mmol/L within the first hour of life, any blood sample) OR a history of asphyxia with Apgar ≤ 5 at 10 minutes or need for ventilatory resuscitation continued at 10 minutes of life * Non-compressed conventional EEG (EEGc) recorded before the 6th hour of life * EEG including the signal of active electrodes Fp1, Fp2, T3 and T4

Exclusion criteria

* Participation in a therapeutic biomedical research liable to modify the EEG tracing * Fewer than 20 minutes of artifact-free EEG recording * Signal from active electrodes Fp1, Fp2, T3 and T4 not exploitable

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity and specificity of the algorithm versus the gold standard for discriminating mild vs moderate/severe HIEWithin the first 6 hours of lifeDiagnostic performance computed against the reference EEG reading by pediatric neurophysiologists complemented by clinical data; 95% confidence intervals by the exact (Clopper-Pearson) method.

Secondary

MeasureTime frameDescription
PPV, NPV, false-alarm ratio, accuracy, balanced accuracy and F1-score of the algorithm vs gold standard (overall and by subgroup)Within the first 6 hours of lifeSecondary diagnostic-performance metrics computed overall and within the treated / untreated subgroups.
Proportion of transfers not leading to therapeutic hypothermiaDuring the initial hospitalization (up to 28 days of life)Share of included newborns not treated by therapeutic hypothermia at the time, including those transferred from a level 1/2a/2b maternity or managed within the same facility.
Evaluate the inter-rater agreement between the first two expert neurophysiologistsEEG recordings from the first 6 hours of lifeInter-rater agreement will be assessed using Cohen's kappa coefficient (κ), with a 95% confidence interval.

Contacts

CONTACTMathilde LETOUZEY, M.D
mathilde.letouzey@aphp.fr+ 33171738599

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 14, 2026